Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection

Detalles Bibliográficos
Autores principales: Snee, M. P., McParland, L., Collinson, F., Lowe, C. M., Striha, A., Baldwin, D. R., Naidu, B., Sebag-Montefiore, D., Gregory, W. M., Bestall, J., Hewison, J., Hinsley, S., Franks, K. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154043/
https://www.ncbi.nlm.nih.gov/pubmed/27976752
http://dx.doi.org/10.1186/s40814-016-0095-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154043/
https://www.ncbi.nlm.nih.gov/pubmed/27976752
http://dx.doi.org/10.1186/s40814-016-0095-6

Ejemplares similares